Literature DB >> 32036029

Examination of nicotine and saccharin reward in the Goto-Kakizaki diabetic rat model.

Janell R Richardson1, Laura E O'Dell2, Arbi Nazarian3.   

Abstract

Morbidity and mortality attributed to type 2 diabetes have exponentially increased in the US. At exceptionally high risk is a subpopulation of persons with type 2 diabetes who smoke, which are shown to have decreased success rates of smoking cessation than euglycemic smokers. Preclinical research in our laboratory has shown that the rewarding effects of nicotine are enhanced in the streptozotocin and high-fat diet rodent model of diabetes. It is presently unclear whether this enhancement of nicotine reward can be demonstrated in other insulin resistant rat models. This study aimed to determine if a similar increase in nicotine reward is found in Goto-Kakizaki (GK) rats, a model of the spontaneous formation of insulin resistance in an inbred sub-strain of Wistar rat. Nicotine conditioned place preference (CPP) was examined in Sprague-Dawley (SD), Wistar, and GK rats. A robust nicotine CPP was found in SD and Wistar rats, but nicotine CPP was not detected in GK rats. Locomotor activity was also evaluated in all three strains, and GK rats demonstrated significantly less activity as compared to SD and Wistar rats. To further assess reward behavior in GK rats, consumption of saccharin solution was measured over a 48 -h period. GK rats showed a significant increase in saccharin intake compared to SD rats. These findings suggest that GK rats experience an enhanced hedonic processing as compared to SD rats. The lack of nicotine CPP in GK rats may be due to deficits in learning and memory, thus hindering their ability to acquire or express a place preference.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes; Goto-Kakizaki; Nicotine reward; Place preference

Mesh:

Substances:

Year:  2020        PMID: 32036029      PMCID: PMC7043340          DOI: 10.1016/j.neulet.2020.134825

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.

Authors:  Joseph A Pipkin; Bryan Cruz; Rodolfo J Flores; Cecilia A Hinojosa; Luis M Carcoba; Melissa Ibarra; Wendy Francis; Arbi Nazarian; Laura E O'Dell
Journal:  Psychopharmacology (Berl)       Date:  2017-03-24       Impact factor: 4.530

2.  Differential behavioral responses to nicotine in Lewis and Fischer-344 rats.

Authors:  Scott D Philibin; Robert E Vann; Stephen A Varvel; Herbert E Covington; John A Rosecrans; John R James; Susan E Robinson
Journal:  Pharmacol Biochem Behav       Date:  2004-11-18       Impact factor: 3.533

3.  Awareness and use of smoking cessation treatments among diabetic patients.

Authors:  G V Gill; C Morgan; I A MacFarlane
Journal:  Diabet Med       Date:  2005-05       Impact factor: 4.359

4.  Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task.

Authors:  Tiago Moreira; Ewa Malec; Claes-Göran Ostenson; Suad Efendic; Sture Liljequist
Journal:  Behav Brain Res       Date:  2007-02-25       Impact factor: 3.332

5.  Hydrocodone and morphine possess similar rewarding effects and reduce ERK and CREB phosphorylation in the nucleus accumbens.

Authors:  John M Tenayuca; Arbi Nazarian
Journal:  Synapse       Date:  2012-07-02       Impact factor: 2.562

6.  (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats.

Authors:  B Horan; M Smith; E L Gardner; M Lepore; C R Ashby
Journal:  Synapse       Date:  1997-05       Impact factor: 2.562

7.  Production of spontaneous diabetic rats by repetition of selective breeding.

Authors:  Y Goto; M Kakizaki; N Masaki
Journal:  Tohoku J Exp Med       Date:  1976-05       Impact factor: 1.848

8.  Wistar Kyoto and Wistar rats differ in the affective and locomotor effects of nicotine.

Authors:  Anthony S Rauhut; Isaac J Zentner; Stacey K Mardekian; Jason B Tanenbaum
Journal:  Physiol Behav       Date:  2007-08-25

9.  Hippocampal neurovascular and hypothalamic-pituitary-adrenal axis alterations in spontaneously type 2 diabetic GK rats.

Authors:  Juan Beauquis; Françoise Homo-Delarche; Marie-Hélène Giroix; Jan Ehses; Josiane Coulaud; Paulina Roig; Bernard Portha; Alejandro F De Nicola; Flavia Saravia
Journal:  Exp Neurol       Date:  2010-01-04       Impact factor: 5.330

10.  Ginsenoside Ameliorates Cognitive Dysfunction in Type 2 Diabetic Goto-Kakizaki Rats.

Authors:  Zhiyan Tian; Ning Ren; Jinghua Wang; Danhong Zhang; Yuying Zhou
Journal:  Med Sci Monit       Date:  2018-06-10
View more
  1 in total

Review 1.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.